Literature DB >> 35438548

Characterization of Induction and Targeting of Senescent Mesenchymal Stromal Cells.

Robert C H Gresham1, Devanshi Kumar2, Jonathan Copp1,3, Mark A Lee1, J Kent Leach1,2.   

Abstract

Mesenchymal stromal cells (MSCs) from older donors have limited potential for bone tissue formation compared with cells from younger donors, and cellular senescence has been postulated as an underlying cause. There is a critical need for methods to induce premature senescence to study this phenomenon efficiently and reproducibly. However, the field lacks consensus on the appropriate method to induce and characterize senescence. Moreover, we have a limited understanding of the effects of commonly used induction methods on senescent phenotype. To address this significant challenge, we assessed the effect of replicative, hydrogen peroxide, etoposide, and irradiation-induced senescence on human MSCs using a battery of senescent cell characteristics. All methods arrested proliferation and resulted in increased cell spreading compared with low passage controls. Etoposide and irradiation increased expression of senescence-related genes in MSCs at early time points, proinflammatory cytokine secretion, DNA damage, and production of senescence-associated β-galactosidase. We then evaluated the effect of fisetin, a flavonoid and candidate senolytic agent, to clear senescent cells and promote osteogenic differentiation of MSCs entrapped in gelatin methacryloyl (GelMA) hydrogels in vitro. When studying a mixture of nonsenescent and senescent MSCs, we did not observe decreases in senescent markers or increases in osteogenesis with fisetin treatment. However, the application of the same treatment toward a heterogeneous population of human bone marrow-derived cells entrapped in GelMA decreased senescent markers and increased osteogenesis after 14 days in culture. These results identify best practices for inducing prematurely senescent MSCs and motivate the need for further study of fisetin as a senolytic agent. Impact Statement The accumulation of senescent cells within the body has detrimental effects on tissue homeostasis. To study the role of senescent cells on tissue repair and regeneration, there is a need for effective means to induce premature cell senescence. Herein, we characterized the influence of common stressors to induce premature senescence in human mesenchymal stromal cells (MSCs). Irradiation of MSCs resulted in a phenotype most similar to quiescent, high-passage cells. These studies establish key biomarkers for evaluation when studying senescent cells in vitro.

Entities:  

Keywords:  MSCs; hydrogel; osteogenesis; senescence; senolytic agent

Mesh:

Substances:

Year:  2022        PMID: 35438548      PMCID: PMC9247679          DOI: 10.1089/ten.TEC.2022.0048

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.273


  40 in total

Review 1.  Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects.

Authors:  Joshua R Mauney; Vladimir Volloch; David L Kaplan
Journal:  Tissue Eng       Date:  2005 May-Jun

2.  Accumulation of senescent cells in mitotic tissue of aging primates.

Authors:  Jessie C Jeyapalan; Mark Ferreira; John M Sedivy; Utz Herbig
Journal:  Mech Ageing Dev       Date:  2006-11-20       Impact factor: 5.432

3.  Biomimetic scaffolds fabricated from apatite-coated polymer microspheres.

Authors:  Hillary E Davis; Rameshwar R Rao; Jiawei He; J Kent Leach
Journal:  J Biomed Mater Res A       Date:  2009-09-15       Impact factor: 4.396

4.  The Clinical Potential of Senolytic Drugs.

Authors:  James L Kirkland; Tamara Tchkonia; Yi Zhu; Laura J Niedernhofer; Paul D Robbins
Journal:  J Am Geriatr Soc       Date:  2017-09-04       Impact factor: 5.562

5.  Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion.

Authors:  Francis Rodier; Jean-Philippe Coppé; Christopher K Patil; Wieteke A M Hoeijmakers; Denise P Muñoz; Saba R Raza; Adam Freund; Eric Campeau; Albert R Davalos; Judith Campisi
Journal:  Nat Cell Biol       Date:  2009-07-13       Impact factor: 28.824

Review 6.  Four faces of cellular senescence.

Authors:  Francis Rodier; Judith Campisi
Journal:  J Cell Biol       Date:  2011-02-14       Impact factor: 10.539

7.  Low dose radiation induced senescence of human mesenchymal stromal cells and impaired the autophagy process.

Authors:  Nicola Alessio; Stefania Del Gaudio; Stefania Capasso; Giovanni Di Bernardo; Salvatore Cappabianca; Marilena Cipollaro; Gianfranco Peluso; Umberto Galderisi
Journal:  Oncotarget       Date:  2015-04-10

8.  The Achilles' heel of senescent cells: from transcriptome to senolytic drugs.

Authors:  Yi Zhu; Tamara Tchkonia; Tamar Pirtskhalava; Adam C Gower; Husheng Ding; Nino Giorgadze; Allyson K Palmer; Yuji Ikeno; Gene B Hubbard; Marc Lenburg; Steven P O'Hara; Nicholas F LaRusso; Jordan D Miller; Carolyn M Roos; Grace C Verzosa; Nathan K LeBrasseur; Jonathan D Wren; Joshua N Farr; Sundeep Khosla; Michael B Stout; Sara J McGowan; Heike Fuhrmann-Stroissnigg; Aditi U Gurkar; Jing Zhao; Debora Colangelo; Akaitz Dorronsoro; Yuan Yuan Ling; Amira S Barghouthy; Diana C Navarro; Tokio Sano; Paul D Robbins; Laura J Niedernhofer; James L Kirkland
Journal:  Aging Cell       Date:  2015-04-22       Impact factor: 9.304

9.  Inhibition of DNA damage response at telomeres improves the detrimental phenotypes of Hutchinson-Gilford Progeria Syndrome.

Authors:  Julio Aguado; Agustin Sola-Carvajal; Valeria Cancila; Gwladys Revêchon; Peh Fern Ong; Corey Winston Jones-Weinert; Emelie Wallén Arzt; Giovanna Lattanzi; Oliver Dreesen; Claudio Tripodo; Francesca Rossiello; Maria Eriksson; Fabrizio d'Adda di Fagagna
Journal:  Nat Commun       Date:  2019-11-18       Impact factor: 14.919

10.  Osteogenic preconditioning in perfusion bioreactors improves vascularization and bone formation by human bone marrow aspirates.

Authors:  J N Harvestine; T Gonzalez-Fernandez; A Sebastian; N R Hum; D C Genetos; G G Loots; J K Leach
Journal:  Sci Adv       Date:  2020-02-12       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.